| Evaluation of olfactory dysfunction in neurodegenerative diseases M Barresi, R Ciurleo, S Giacoppo, VF Cuzzola, D Celi, P Bramanti, ... Journal of the neurological sciences 323 (1-2), 16-24, 2012 | 243 | 2012 |
| 5-Arylidene-2, 4-thiazolidinediones as inhibitors of protein tyrosine phosphatases R Maccari, P Paoli, R Ottanà, M Jacomelli, R Ciurleo, G Manao, T Steindl, ... Bioorganic & medicinal chemistry 15 (15), 5137-5149, 2007 | 143 | 2007 |
| Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored … P Fagone, R Ciurleo, SD Lombardo, C Iacobello, CI Palermo, ... Autoimmunity reviews 19 (7), 102571, 2020 | 112 | 2020 |
| 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors R Ottanà, R Maccari, R Ciurleo, P Paoli, M Jacomelli, G Manao, G Camici, ... Bioorganic & medicinal chemistry 17 (5), 1928-1937, 2009 | 110 | 2009 |
| Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives E Cavalli, A Bramanti, R Ciurleo, AI Tchorbanov, A Giordano, P Fagone, ... International journal of molecular medicine 46 (3), 903-912, 2020 | 99 | 2020 |
| Evaluation of in vitro aldose redutase inhibitory activity of 5-arylidene-2, 4-thiazolidinediones R Maccari, R Ottanà, R Ciurleo, MG Vigorita, D Rakowitz, T Steindl, ... Bioorganic & medicinal chemistry letters 17 (14), 3886-3893, 2007 | 80 | 2007 |
| 1H-MR Spectroscopy in Traumatic Brain Injury S Marino, R Ciurleo, P Bramanti, A Federico, N De Stefano Neurocritical care 14, 127-133, 2011 | 77 | 2011 |
| Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2, 4-thiazolidinedione derivatives R Maccari, R Ottanà, R Ciurleo, D Rakowitz, B Matuszczak, C Laggner, ... Bioorganic & medicinal chemistry 16 (11), 5840-5852, 2008 | 76 | 2008 |
| Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson’s disease? R Ciurleo, G Di Lorenzo, P Bramanti, S Marino BioMed Research International 2014 (1), 519816, 2014 | 70 | 2014 |
| Role of resveratrol and its analogues in the treatment of neurodegenerative diseases: focus on recent discoveries V Foti Cuzzola, R Ciurleo, S Giacoppo, S Marino, P Bramanti CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2011 | 66 | 2011 |
| Role of statins in the treatment of multiple sclerosis R Ciurleo, P Bramanti, S Marino Pharmacological research 87, 133-143, 2014 | 65 | 2014 |
| Pharmacotherapy for disorders of consciousness: are ‘awakening’drugs really a possibility? R Ciurleo, P Bramanti, RS Calabrò Drugs 73, 1849-1862, 2013 | 63 | 2013 |
| Comprehensive analysis of RNA-seq gene expression profiling of brain transcriptomes reveals novel genes, regulators, and pathways in autism spectrum disorder MR Rahman, MC Petralia, R Ciurleo, A Bramanti, P Fagone, ... Brain sciences 10 (10), 747, 2020 | 56 | 2020 |
| Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures R Ottanà, R Maccari, R Ciurleo, MG Vigorita, AM Panico, V Cardile, ... Bioorganic & medicinal chemistry 15 (24), 7618-7625, 2007 | 55 | 2007 |
| Emerging neurological and psychobiological aspects of COVID-19 infection L Tancheva, MC Petralia, S Miteva, S Dragomanova, A Solak, R Kalfin, ... Brain sciences 10 (11), 852, 2020 | 53 | 2020 |
| Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? E Cavalli, R Ciurleo, MC Petralia, P Fagone, R Bella, K Mangano, ... Molecules 25 (5), 1194, 2020 | 49 | 2020 |
| Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis F Caminiti, S De Salvo, MC De Cola, M Russo, P Bramanti, S Marino, ... PloS one 9 (7), e103151, 2014 | 49 | 2014 |
| Identification of new non-carboxylic acid containing inhibitors of aldose reductase R Maccari, R Ciurleo, M Giglio, M Cappiello, R Moschini, A Del Corso, ... Bioorganic & medicinal chemistry 18 (11), 4049-4055, 2010 | 49 | 2010 |
| Magnetic resonance imaging markers for early diagnosis of Parkinson's disease☆ S Marino, R Ciurleo, G Di Lorenzo, M Barresi, S De Salvo, S Giacoppo, ... Neural regeneration research 7 (8), 611-619, 2012 | 42 | 2012 |
| Cognitive decline in rheumatoid arthritis: Insight into the molecular pathogenetic mechanisms MS Basile, R Ciurleo, A Bramanti, MC Petralia, P Fagone, F Nicoletti, ... International journal of molecular sciences 22 (3), 1185, 2021 | 41 | 2021 |
